Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex
- 1 November 2002
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 51 (11) , 937-940
- https://doi.org/10.1099/0022-1317-51-11-937
Abstract
The Burkholderia cepacia complex presently comprises nine genomovars: B. cepacia (genomovar I), B. multivorans (genomovar II), B. cepacia genomovar III, B. stabilis (genomovar IV), B. vietnamiensis (genomovar V), B. cepacia genomovar VI, B. ambifaria (genomovar VII), B. anthina (genomovar VIII) and B. pyrrocinia (genomovar IX). Strains of each genomovar can colonise the respiratory tract of cystic fibrosis (CF) patients. However, the majority of infections in CF patients are caused by B. multivorans and B. cepacia genomovar III isolates. Accurate genomovar-level identification is best achieved through a polyphasic approach combining phenotypic and genotypic analyses. In the present study, the sensitivity and specificity of recA-based genomovar specific primer pairs were evaluated with a collection of 508 B. cepacia complex isolates representing all nine genomovars. The assays for the identification of B. multivorans (sensitivity and specificity, 100%), B. cepacia genomovar III (sensitivity, 92%; specificity, 100%), and B. ambifaria (sensitivity and specificity, 100%) were the most efficient. However, the B. cepacia genomovar I assay lacked sensitivity (72%) and cross-reacted with all B. pyrrocinia isolates examined. Several new recA RFLP types were also revealed within the B. cepacia complex. One of these profiles was shared by a clinical and an environmental B. cepacia-like isolate and by the B. ubonensis type strain. The latter organism is a recently described soil bacterium. Its relationship to the various B. cepacia complex genomovars needs further study.Keywords
This publication has 28 references indexed in Scilit:
- Disproportionate Distribution of Burkholderia cepacia Complex Species and Transmissibility Markers in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.International Journal of Systematic and Evolutionary Microbiology, 2001
- BURKHOLDERIA CEPACIAClinics in Chest Medicine, 1998
- Occurrence of Multiple Genomovars of Burkholderia cepacia in Cystic Fibrosis Patients and Proposal of Burkholderia multivorans sp. nov.International Journal of Systematic and Evolutionary Microbiology, 1997
- Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.Thorax, 1996
- Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosisThe Lancet, 1993
- The epidemiology of nosocomial epidemic Pseudomonas cepacia infectionsEuropean Journal of Epidemiology, 1987
- Pseudomonas cepacia: An emerging pathogen in chronic granulomatous diseaseThe Journal of Pediatrics, 1986
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984
- Antibiotic prophylaxis in cystic fibrosis: Inhaled cephaloridine as an adjunct to oral cloxacillinThe Journal of Pediatrics, 1982